Healthcare -
Biotechnology - NASDAQ - US
$ 4.465
-1.22 %
$ 399 M
Market Cap
-10.15
P/E
TRVI - EPS
EPS TRVI - Trevi Therapeutics, Inc.
-0.29
LAST VALUE
55.88%
2 YEAR CAGR
33.85%
5 YEAR CAGR
0.00%
10 YEAR CAGR